This content is from: Premium

VC Financing Is Down, But Not Out

At least four hedge funds participated in three of the largest private financings in October, with biotech leading the way.

Venture capital financing volume may have shriveled to multiyear lows, but there are still sizable deals being completed.According to, at least five private companies each raised more than $260 million in October, although there were none of the $1 billion fundraising rounds seen in September.“Biotech played a starring role

To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.

Related Content